Prognostic significance of immunohistochemical expression of EGFR and C-erbB-2 oncoprotein in curatively resected gastric cancer.
about
HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the LiteratureThe prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancerClinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes--a systematic review.The effect of epiregulin on epidermal growth factor receptor expression and proliferation of oral squamous cell carcinoma cell lines.The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literatureClinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer.Effect of epidermal growth factor receptor status on the outcomes of patients with metastatic gastric cancer: A pilot study.IGF-IR cooperates with ERα to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM moleculesRole of human epidermal growth factor receptor 2 in gastric cancer: biological and pharmacological aspects.Evolving standards of care in advanced gastric cancer.Metastatic gastric cancer treatment: a little slow but worthy progress.An independent survival prognostic role for human epidermal growth factor receptor 2 in gastric cancer: evidence from a meta-analysis.Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysisEvaluation of the Expression of the Human Epithelial Receptor 2 (HER2) in Gastric Carcinoma.The prognostic impact of EGFR, ErbB2 and MET gene amplification in human gastric carcinomas as measured by quantitative Real-Time PCR.
P2860
Q34223664-C9D98C24-4A29-4D09-8831-8A0E1FE2424DQ34478504-29CF1693-9BB2-4334-9D3E-8C8C78757488Q34631121-6074B7F4-882B-465B-8D54-98BBA397BDB5Q35357793-0289CEFF-4FF3-460B-8BB5-2DE076DF8D44Q36317603-C4817321-A55D-4ADF-87DC-BABE5BC1882DQ36648866-10569E94-3F9A-4310-84F9-3EF929F93594Q37388719-61B4C435-A8AF-47F7-B872-5DE5A38C326EQ37581720-2B4AF733-B0F7-4669-B47D-FEE4E28F8101Q37724647-D2AE4A93-9D32-4B4A-8CEF-2583A3A99293Q37960206-C0E9548E-E4D4-4062-AF70-C2275B209977Q38075499-701B83DB-CDA9-41E1-AFC2-ACAB5D8A5971Q38691748-6AE207B8-5BC5-4356-8964-DB5BD50B612CQ40332121-1D7BBE3A-9AF8-4FB6-B332-1D295EEDBCCBQ51180085-ECBD1C64-6B58-4548-9105-B8DC9C1230FDQ53562884-645FF376-E0DE-4961-9E2E-E8942C83C99C
P2860
Prognostic significance of immunohistochemical expression of EGFR and C-erbB-2 oncoprotein in curatively resected gastric cancer.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Prognostic significance of imm ...... ively resected gastric cancer.
@ast
Prognostic significance of imm ...... ively resected gastric cancer.
@en
type
label
Prognostic significance of imm ...... ively resected gastric cancer.
@ast
Prognostic significance of imm ...... ively resected gastric cancer.
@en
prefLabel
Prognostic significance of imm ...... ively resected gastric cancer.
@ast
Prognostic significance of imm ...... ively resected gastric cancer.
@en
P2093
P2860
P1476
Prognostic significance of imm ...... ively resected gastric cancer.
@en
P2093
Hong Suk Song
Kun Young Kwon
Soo Sang Sohn
Young Rok Do
P2860
P304
P356
10.4143/CRT.2004.36.4.240
P577
2004-08-31T00:00:00Z